Series A · Healthtech
Combat Medical: Series A
Develops hyperthermic intravesical chemotherapy treatment for BCG unresponsive bladder cancer
Funding history
Series A · This round£2.6M
Loading rounds…
Develops hyperthermic intravesical chemotherapy treatment for BCG unresponsive bladder cancer